Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
Condition(s):Glioblastoma Multiforme; Gliosarcoma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; GliomaLast Updated:November 21, 2012Withdrawn
Hide Studies Not Open or Pending
Condition(s):Glioblastoma Multiforme; Gliosarcoma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; GliomaLast Updated:November 21, 2012Withdrawn
Condition(s):Epilepsy With Simple or Complex Partial Onset SeizuresLast Updated:March 11, 2016Completed
Condition(s):Epilepsy; Seizure; Cognition DisordersLast Updated:November 11, 2013Completed
Condition(s):Epilepsy; PregnancyLast Updated:July 13, 2023Completed
Condition(s):Epilepsy; Neuropathy; Psychiatric Illness; BlepharospasmLast Updated:September 5, 2018Unknown status
Condition(s):Epilepsy; Magnesium Deficiency; Vitamin D DeficiencyLast Updated:March 1, 2021Terminated
Condition(s):EpilepsyLast Updated:October 24, 2016Completed
Condition(s):Epilepsy; ContraceptionLast Updated:January 18, 2016Completed
Condition(s):EpilepsyLast Updated:May 13, 2013Completed
Condition(s):Refractory Partial SeizuresLast Updated:February 7, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.